AstraZeneca may sell some of its medicines directly to patients in the US, according to Chief Executive Officer Pascal Soriot.  AstraZeneca is looking to the US for growth, with Soriot saying the company will be self-sufficient in the US in a couple of months. He speaks with Bloomberg's Carol Massar, Tim Stenovec, and Madison Muller

AstraZeneca may sell some of its medicines directly to patients in the US, according to Chief Executive Officer Pascal Soriot.&nbsp;&nbsp;AstraZeneca is looking to the US for growth, with Soriot saying the company will be self-sufficient in the US in a couple of months. He speaks with Bloomberg's Carol Massar, Tim Stenovec, and Madison Muller

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment.

Listen for top interviews from Bloomberg News. Hear conversations with the biggest names in finance, politics and entertainment.

Listen to top interviews from Bloomberg News.

Bloomberg Talks

AstraZeneca CEO Talks Drug Sales in US

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/233713a7-9e8a-48b6-a980-b329013fceb6/transcript

Daron Acemoglu, Institute Professor in the Department of Economics at the Massachusetts Institute of Technology, talks with Bloomberg's Carol Massar and Tim Steneovec about his Bloomberg Businessweek article detailing his “Unified Theory of Trump”.

Daron Acemoglu, Institute Professor in the Department of Economics at the Massachusetts Institute of Technology, talks with Bloomberg's Carol Massar and Tim Steneovec about his Bloomberg Businessweek article detailing his &ldquo;Unified Theory of Trump&rdquo;.

Daron Acemoglu Talks Theory of Trump

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/fea1630f-45b6-4515-a497-b3d401458869/transcript

Tech companies no longer need creative workarounds, like acquihires, to get M&A deals through, says Federal Trade Commission Chair Andrew Ferguson. Ferguson says the commission will review these deals to make sure they comply with the law. He joins Bloomberg's Ed Ludlow. 

Tech companies no longer need creative workarounds, like acquihires, to get M&amp;A deals through, says Federal Trade Commission Chair Andrew Ferguson. Ferguson says the commission will review these deals to make sure they comply with the law. He joins Bloomberg's Ed Ludlow.&nbsp;

FTC Chair Andrew Ferguson Talks Acquihires

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/411fac0a-1d08-44ef-a276-b3d4012d56b9/transcript

New York Times Financial Journalist and Author Andrew Ross Sorkin talks with Bloomberg's Carol Massar and Tim Stenovec about his newest book published in October 2025 titled "1929" about the stock market crash of the titular year. 

New York Times Financial Journalist and Author Andrew Ross Sorkin talks with Bloomberg's Carol Massar and Tim Stenovec about his newest book published in October 2025 titled "1929" about the stock market crash of the titular year.&nbsp;

Andrew Ross Sorkin Talks Newest Book, Comparison to Modern Times

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/ca6735f5-f4a1-4e97-857d-b3d301822544/transcript

AstraZeneca CEO Talks Drug Sales in US

In 1 playlist(s)

Bloomberg Talks

Social links

Follow podcast

Recent clips